How we treat HER2-positive brain metastases
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference23 articles.
1. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype;Arvold;Breast Cancer Res Treat,2012
2. Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG);Pestalozzi;Ann Oncol,2006
3. CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01);Pestalozzi;Lancet Oncol,2013
4. Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: results from the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial;Piccart-Gebhart;J Clin Oncol,2016
5. Trastuzumab emtansine for residual invasive HER2-positive breast cancer;von Minckwitz;N Engl J Med,2019
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Leveraging preclinical models of metastatic breast cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09
2. Effect of HER2-low status on brain metastasis-free survival and survival after brain metastasis in patients with breast cancer;Clinical and Translational Oncology;2024-08-10
3. New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful?;Cancers;2024-07-05
4. Trastuzumab Deruxtecan in brain metastases from breast cancer: outcome analysis of real life population;2024-06-11
5. Electrophysiological and morphological modulation of neuronal-glial network by breast cancer and nontumorigenic mammary cell conditioned medium;Frontiers in Bioengineering and Biotechnology;2024-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3